⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 12, 2024Open Access

Supplementary Figure 3 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein

Joseph P. Gallant Hallie M. Hintz Gihan S. Gunaratne Matthew T. Breneman Emma E. Recchia Jayden L. West Kendahl L. Ott Erika Héninger Abigail E. Jackson Natalie Y. Luo Zachary T. Rosenkrans Reinier Hernandez Shuang G. Zhao Joshua M. Lang Labros Meimetis David Kosoff Aaron M. LeBeau

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Determining the therapeutic window in the Stacks

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gallant et al. (2024) studied this question.

synapsesocial.com/papers/68e651c0b6db6435875e1d2e https://doi.org/10.1158/2767-9764.26023163.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 3 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein2024
2Supplementary Figure 1 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein2024
3Supplementary Figure 1 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein2024
4Supplementary Figure 2 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein2024
5FIGURE 4 from Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody–Drug Conjugate Targeting Fibroblast Activation Protein2024